NEK9 and melanoma: siRNA‐mediated knockdown of NEK9 using siRNA pools from two manufacturers (siNEK9#1 and #2) reduced the growth of both BRAF‐mutant (1205Lu) and NRAS‐mutant (WM1366, IPC‐298, and M245) melanoma cell lines (Fig. 4A and Fig. S5).